Viewing Study NCT00042393


Ignite Creation Date: 2025-12-25 @ 1:07 AM
Ignite Modification Date: 2026-01-20 @ 9:59 PM
Study NCT ID: NCT00042393
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2014-01-07
First Post: 2002-07-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options
Sponsor: Gilead Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hepatitis B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatitis B, Chronic View